Role neoadjuvant chemotherapy in ca cervix
•Download as PPTX, PDF•
4 likes•916 views
This document compares survival rates for patients with locally advanced cervical cancer who received chemotherapy plus radiotherapy versus radiotherapy alone across several studies from the 1990s. It shows that in 4 out of 7 studies, the combination of chemotherapy and radiotherapy resulted in improved overall survival rates compared to radiotherapy alone, with statistically significant improvements in 2 studies using epirubicin/cisplatin or bleomycin/vincristine/mitomycin/cisplatin combinations. However, 3 studies found no significant difference in survival between the two treatment approaches.
Report
Share
Report
Share
Recommended
Update on clinical trials in cervical cancer
Congreso de cáncer de cérvix, organizado por René Pareja, Lina Trujillo y Claudia Calle, Hotel Interecontinental Medellín, Junio 22-24, 2017
EBRT IN CARCINOMA CERVIX
1) Radiotherapy plays an important role in managing carcinoma of the cervix by delivering high doses through a combination of external beam radiotherapy and brachytherapy.
2) The disease has central and peripheral components - the central component confined to the cervix is best treated with brachytherapy, while the peripheral component involving surrounding tissues is treated with both external beam radiotherapy and brachytherapy.
3) External beam radiotherapy techniques include 3D conformal radiotherapy and IMRT to improve dose distribution and spare surrounding organs-at-risk.
Landmark trials in breast cancer.pptx
Landmark trials in the evolution of surgery, radiotherapy and systemic anti-cancer therapy (chemotherapy, hormonal treatment etc.) in breast cancer
Endometrial cancer recommendations
This document provides guidelines for the management of endometrial cancer from several European medical societies. It covers epidemiology, risk assessment, surgery, lymph node staging, adjuvant therapy, and management of early, advanced, and recurrent disease. Key points include recommending total hysterectomy and bilateral salpingo-oophorectomy for staging without vaginal cuff resection for early-stage disease. It also supports consideration of sentinel lymph node biopsy for staging in select cases and ovarian preservation in certain low-risk premenopausal patients. Molecular testing is encouraged to further stratify prognosis, especially in high-grade tumors.
Breast landmark trials dr.kiran
This document summarizes several landmark clinical trials in breast cancer treatment. It describes trials that tested chemoprevention drugs like tamoxifen to reduce breast cancer risk. It also summarizes radiation therapy trials comparing lumpectomy alone to lumpectomy with radiation. Further, it summarizes trials comparing breast-conserving surgery and radiation to mastectomy. The document finds that radiation after lumpectomy and mastectomy radiation for node-positive patients improve outcomes.
Radiotherapy planning for vulvar cancer September 2020
This document discusses radiotherapy planning for vulvar cancer. It begins with an introduction that notes vulvar cancer is rare but usually presents as early stage squamous cell carcinoma in elderly women. It then covers anatomy, lymphatic spread, investigations, staging, indications for radiotherapy, patient positioning and immobilization, target volumes, field arrangements, doses, and toxicities. The target volumes include the vulvar tumor bed, inguinal lymph nodes, and sometimes pelvic lymph nodes. Doses depend on whether radiotherapy is adjuvant or definitive and if there is gross disease or positive margins. Toxicities are a concern especially for organs at risk like the bowels and bladder.
Radiotherapy planning in carcinoma cervix dr rekha
This document discusses radiotherapy planning and techniques for treating carcinoma of the cervix. It describes conformal radiotherapy which aims to deliver a high dose to the target volume while minimizing dose to surrounding tissues. Intensity-modulated radiotherapy (IMRT) is recommended to reduce toxicities to organs near the cervix such as the small bowel, rectum, and bladder. The workflow of conformal radiotherapy involves patient positioning using devices, immobilization, image acquisition with CT and/or MRI, treatment planning using defined target volumes and organs at risk, and dose prescription according to ICRU guidelines.
Neoadjuvant chemotherapy ver 2.0
Neoadjuvant chemotherapy uses chemotherapy drugs to shrink tumors before surgery. It has several advantages, including allowing previously inoperable tumors to become operable, preserving organs, and improving long-term survival. Some studies have found higher rates of pathological complete response and progression-free survival with neoadjuvant chemoradiotherapy compared to chemotherapy alone for some cancers. Neoadjuvant chemotherapy has been shown to be as effective as adjuvant chemotherapy for some cancers. However, it can also be more difficult for patients due to its cumulative toxicity and longer duration before definitive surgery. It may be recommended as an alternative to adjuvant therapy for operable breast cancers where breast conservation is desired or surgery is not immediately possible.
Recommended
Update on clinical trials in cervical cancer
Congreso de cáncer de cérvix, organizado por René Pareja, Lina Trujillo y Claudia Calle, Hotel Interecontinental Medellín, Junio 22-24, 2017
EBRT IN CARCINOMA CERVIX
1) Radiotherapy plays an important role in managing carcinoma of the cervix by delivering high doses through a combination of external beam radiotherapy and brachytherapy.
2) The disease has central and peripheral components - the central component confined to the cervix is best treated with brachytherapy, while the peripheral component involving surrounding tissues is treated with both external beam radiotherapy and brachytherapy.
3) External beam radiotherapy techniques include 3D conformal radiotherapy and IMRT to improve dose distribution and spare surrounding organs-at-risk.
Landmark trials in breast cancer.pptx
Landmark trials in the evolution of surgery, radiotherapy and systemic anti-cancer therapy (chemotherapy, hormonal treatment etc.) in breast cancer
Endometrial cancer recommendations
This document provides guidelines for the management of endometrial cancer from several European medical societies. It covers epidemiology, risk assessment, surgery, lymph node staging, adjuvant therapy, and management of early, advanced, and recurrent disease. Key points include recommending total hysterectomy and bilateral salpingo-oophorectomy for staging without vaginal cuff resection for early-stage disease. It also supports consideration of sentinel lymph node biopsy for staging in select cases and ovarian preservation in certain low-risk premenopausal patients. Molecular testing is encouraged to further stratify prognosis, especially in high-grade tumors.
Breast landmark trials dr.kiran
This document summarizes several landmark clinical trials in breast cancer treatment. It describes trials that tested chemoprevention drugs like tamoxifen to reduce breast cancer risk. It also summarizes radiation therapy trials comparing lumpectomy alone to lumpectomy with radiation. Further, it summarizes trials comparing breast-conserving surgery and radiation to mastectomy. The document finds that radiation after lumpectomy and mastectomy radiation for node-positive patients improve outcomes.
Radiotherapy planning for vulvar cancer September 2020
This document discusses radiotherapy planning for vulvar cancer. It begins with an introduction that notes vulvar cancer is rare but usually presents as early stage squamous cell carcinoma in elderly women. It then covers anatomy, lymphatic spread, investigations, staging, indications for radiotherapy, patient positioning and immobilization, target volumes, field arrangements, doses, and toxicities. The target volumes include the vulvar tumor bed, inguinal lymph nodes, and sometimes pelvic lymph nodes. Doses depend on whether radiotherapy is adjuvant or definitive and if there is gross disease or positive margins. Toxicities are a concern especially for organs at risk like the bowels and bladder.
Radiotherapy planning in carcinoma cervix dr rekha
This document discusses radiotherapy planning and techniques for treating carcinoma of the cervix. It describes conformal radiotherapy which aims to deliver a high dose to the target volume while minimizing dose to surrounding tissues. Intensity-modulated radiotherapy (IMRT) is recommended to reduce toxicities to organs near the cervix such as the small bowel, rectum, and bladder. The workflow of conformal radiotherapy involves patient positioning using devices, immobilization, image acquisition with CT and/or MRI, treatment planning using defined target volumes and organs at risk, and dose prescription according to ICRU guidelines.
Neoadjuvant chemotherapy ver 2.0
Neoadjuvant chemotherapy uses chemotherapy drugs to shrink tumors before surgery. It has several advantages, including allowing previously inoperable tumors to become operable, preserving organs, and improving long-term survival. Some studies have found higher rates of pathological complete response and progression-free survival with neoadjuvant chemoradiotherapy compared to chemotherapy alone for some cancers. Neoadjuvant chemotherapy has been shown to be as effective as adjuvant chemotherapy for some cancers. However, it can also be more difficult for patients due to its cumulative toxicity and longer duration before definitive surgery. It may be recommended as an alternative to adjuvant therapy for operable breast cancers where breast conservation is desired or surgery is not immediately possible.
Radiation therapy in wilms tumour
1. Radiation therapy plays an important role in the treatment of Wilms tumor, especially for advanced or high-risk cases.
2. It is used preoperatively, postoperatively, and for metastatic disease to reduce the risk of recurrence.
3. The indications and techniques for radiation therapy depend on factors like tumor stage, histology, response to chemotherapy, and whether metastases are present. Precise radiation treatment planning is required to effectively target tumors while sparing healthy tissues.
Ca Cervix Dr Naresh Jakhotia
The document discusses the non-surgical management of carcinoma cervix. It describes the FIGO staging system and evaluation procedures. For early stage disease (IA-IB1), options include radical hysterectomy or radiotherapy. For stage IB2-IIA, concurrent chemoradiation is the standard treatment. Brachytherapy is an essential component of definitive treatment and aims to deliver high radiation doses to the cervix and paracervical tissues. Proper radiation treatment planning and adherence to timelines are important to achieve optimal outcomes while minimizing toxicity.
Cervix External Beam Radiotherapy techniques
Management of cacrinoma cervix: Techniques of radiotherapy (2D conventional, 3D Conformal radiotherapy (3DCRT) and IMRT with a review of various contouring guidelines.
IMRT and 3D CRT in cervical Cancers
IMRT and 3 DCRT in cervical Cancers - Principles, Uses, Methods and Planning. A short summary of results of contemporary series are also provided.
Accelerated partial breast irradiation
Accelerated partial breast irradiation (APBI) delivers radiation to only the portion of the breast at highest risk of recurrence rather than the whole breast. This allows radiation to be delivered in a significantly shortened period. Several techniques for APBI exist including brachytherapy using catheters implanted in the breast, balloon brachytherapy, and external beam radiotherapy. Ongoing clinical trials are evaluating outcomes and toxicities of APBI compared to whole breast irradiation in appropriately selected patients with early-stage breast cancer.
Cervical carcinoma
This document provides information on carcinoma of the cervix, including epidemiology, risk factors, diagnosis, pathology, stages of pre-invasive and invasive lesions. It discusses that carcinoma of the cervix is the most common genital cancer in India, accounting for 15% of cancers in women. Risk factors include early age of first sexual intercourse, multiple partners, early first pregnancy, and infections like HIV and HPV. Screening is mainly done via Pap smear but can be improved with HPV testing, visual inspection with acetic acid, and colposcopy if needed. Pre-invasive lesions are classified as CIN I-III. Invasive cancers are mostly squamous cell carcinoma or adenocarcinoma, and treatment depends on
Radiotherapy lymphoma
Radiotherapy is used as primary treatment for early-stage Hodgkin lymphoma or as part of combined modality treatment with chemotherapy. Historically, large mantle fields covering lymph node regions from the skull to the pelvis were used. More modern approaches use smaller involved field radiotherapy targeting only initially involved lymph node regions after chemotherapy based on imaging. Proper delineation of clinical target volumes requires pre-chemotherapy imaging ideally with PET/CT to define original disease extent.
Breast Cancer Radiotherapy
This document summarizes recent developments in breast cancer radiotherapy. It discusses a recent meta-analysis of breast cancer radiotherapy trials involving 42,000 women which found that radiotherapy reduces 15-year breast cancer mortality by 5-10% and overall mortality by 4.4%, compared to no radiotherapy. Newer targeted radiotherapy techniques like partial breast irradiation and intensity-modulated radiation therapy (IMRT) are explored which may improve outcomes by more conformally targeting radiation doses to the breast tissue and reducing doses to nearby organs. However, long-term data on these newer techniques is still pending and questions remain around patient selection and appropriate treatment margins.
Sarcoma brachytherapy updates
Brachytherapy improves local control rates for soft tissue sarcomas of the extremities when used as adjuvant therapy after surgery. Interstitial brachytherapy results in 5-year local control rates of 82% for high-grade lesions compared to 69% without brachytherapy. Deeper and larger tumors have worse outcomes, while doses over 60 Gy provide better local control, disease-free survival, and overall survival. Recent data shows intensity-modulated radiation therapy may provide similar local control to brachytherapy with fewer complications. Brachytherapy remains useful for sites where target volumes are extensive or critical structures preclude external beam radiation.
Petct In Gynecologic Cancer
1. PET/CT is useful for diagnosing and staging gynecologic cancers like cervical and ovarian cancer by identifying lymph node and distant metastases that may be missed by conventional methods.
2. A study of 120 cervical cancer patients found that PET/CT identified more extensive disease in 20% of patients compared to conventional staging, including para-aortic lymph node metastases.
3. PET/CT improves radiotherapy planning for cervical cancer by precisely locating tumor tissue and organs at risk, allowing dose escalation with techniques like IMRT while reducing dose to surrounding healthy tissues.
Radiation therapy in gynecologic cancer 17-03-15
Radiation therapy in gynecologic cancer 17-03-15Mahatma Gandhi Medical college & Research Institute - Pondicherry
Radiation therapy plays a major role in treating gynecologic cancers. Developments like X-rays, radium, and artificial radionuclides allowed radiation therapy to be used for various malignancies. Modern linear accelerators and brachytherapy machines deliver external beam radiation therapy or implant radioactive sources. Treatment aims to maximize tumor cell death while minimizing damage to healthy cells. Intensity modulated radiation therapy further improves this goal by conforming the dose to the tumor shape. Developments like image-guided radiation therapy help account for organ motion and changes during treatment. Radiation therapy combined with chemotherapy and surgery provides improved outcomes for cervical and endometrial cancers compared to radiation alone.Adjuvant radiation based on genomic risk factors emerging scenarios
Presentation on tailoring adjuvant radiotherapy for breast cancers based on Genomic risk prediction methods - a review. Presented in MVR CANCON 2018
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
1) Surface guided radiotherapy uses optical cameras to track the external surface of a patient in real-time during treatment and provides sub-millimeter accuracy for patient positioning and motion management.
2) The technique has been used at MSKCC for several clinical applications including frameless SRS for brain tumors, head and neck cancers, and deep inspiratory breath hold treatments for breast cancers.
3) Preliminary results found surface guided radiotherapy improved patient comfort for frameless SRS over framed SRS and doubled the treatment throughput. Motion tracking also ensured frameless SRS accuracy to within 1mm.
Oligometastases
Overview about evolution of the term Oligometastases,the paradigm and various states of oligometastases,treat options ,clinical trials and relevance in current clinical practice
CA ENDOMETRIUM-KIRAN.pptx
1) Endometrial cancer is the most common gynecologic cancer in developed countries, with a lifetime risk of 1 in 35 women. It occurs most often in postmenopausal women.
2) Diagnosis involves endometrial biopsy or dilation and curettage to obtain tissue samples. Staging involves total abdominal hysterectomy and bilateral salpingo-oophorectomy.
3) For low-risk early-stage disease, no additional treatment is typically needed. For high-risk early-stage disease, adjuvant pelvic radiation with or without chemotherapy is recommended based on trials such as PORTEC-3.
Volumetric Modulated Arc Therapy
This document discusses the clinical implementation of volumetric modulated arc therapy (VMAT) at UT M.D. Anderson Cancer Center. It provides an overview of VMAT, the advantages it offers over other radiation therapy techniques, and the steps taken to configure the accelerator, treatment planning system, and quality assurance processes for VMAT delivery. Key aspects covered include accelerator prerequisites, TPS commissioning, patient-specific quality assurance using films and ion chambers, monthly constancy checks, and tips for rapid arc treatment planning for prostate cases.
Radiotherapy for Prostate Cancer
This document discusses radiation therapy options for prostate cancer. It notes that treatment depends on risk level: low risk may receive external beam radiation or seeds alone, intermediate risk should receive some external beam, and high risk should receive hormone therapy plus radiation. Newer techniques like IMRT and IGRT reduce side effects by more precisely targeting the prostate. Side effects of radiation include short term issues like urinary frequency and diarrhea as well as long term risks like radiation cystitis and impotence in some cases.
image guided brachytherapy carcinoma cervix
IMAGE GUIDED BARCHYTHERAPY
AMERICAN BRACHYTHERAPY GUIDELINES
GEC-ESTRO GUIDELINES
LIMITATIONS OF (2 D)RADIOGRAPHIC IMAGING
VOLUMETRIC IMAGING
ADVANCES
Hemi body irradiation
This document discusses hemi body irradiation (HBI) technique used to treat metastatic cancer. HBI involves irradiating only the upper or lower half of the body using parallel opposed radiation fields. It has advantages over total body irradiation like smaller field size and less side effects. HBI is used to palliate widely metastatic disease and as adjuvant therapy for certain cancers. Potential complications include nausea, diarrhea, pneumonitis and hematological effects. The document also provides an overview of cancer registries in India, which systematically collect cancer data to help understand cancer patterns and guide control programs. Population-based and hospital-based registries use active and passive methods to collect data on cancer incidence, stages and survival.
carcinoma breast RADIOTHERAPY TECHNIQUES
This document discusses various radiation therapy techniques for breast carcinoma, including indications for radiation, simulation techniques, post-mastectomy radiation techniques, nodal irradiation techniques, contouring guidelines, boost techniques after breast conservation surgery, intensity modulated radiation therapy (IMRT), and accelerated partial breast irradiation (APBI). It covers topics such as treatment positioning and fields, target volume delineation, dose schedules, and techniques for nodal irradiation and tumor bed boosting.
Stereotactic radiosurgery and radiotherapy
This document discusses stereotactic radiosurgery and radiotherapy. It begins with an introduction to stereotaxy and how it allows for highly precise radiation targeting. It then covers radiobiology concepts relevant to stereotactic radiation and lists some common indications for its use, including brain metastases and early stage prostate cancer. The document provides details on patient immobilization, planning techniques, and treatment procedures for conditions like pituitary adenomas, trigeminal neuralgia, and arteriovenous malformations.
Stereotactic radiosurgery in arterio venous malformations
Stereotactic radiosurgery (SRS) is an effective treatment for arteriovenous malformations (AVMs). SRS precisely delivers high doses of radiation to the AVM nidus, resulting in progressive occlusion of vessels within 1-3 years. Obliteration rates after SRS range from 35-92%, with higher rates for smaller AVMs receiving higher radiation doses. Careful targeting of the AVM nidus using fusion of imaging modalities is important for treatment planning. Long-term follow up with MRI is needed to monitor for obliteration and potential radiation-related effects.
More Related Content
What's hot
Radiation therapy in wilms tumour
1. Radiation therapy plays an important role in the treatment of Wilms tumor, especially for advanced or high-risk cases.
2. It is used preoperatively, postoperatively, and for metastatic disease to reduce the risk of recurrence.
3. The indications and techniques for radiation therapy depend on factors like tumor stage, histology, response to chemotherapy, and whether metastases are present. Precise radiation treatment planning is required to effectively target tumors while sparing healthy tissues.
Ca Cervix Dr Naresh Jakhotia
The document discusses the non-surgical management of carcinoma cervix. It describes the FIGO staging system and evaluation procedures. For early stage disease (IA-IB1), options include radical hysterectomy or radiotherapy. For stage IB2-IIA, concurrent chemoradiation is the standard treatment. Brachytherapy is an essential component of definitive treatment and aims to deliver high radiation doses to the cervix and paracervical tissues. Proper radiation treatment planning and adherence to timelines are important to achieve optimal outcomes while minimizing toxicity.
Cervix External Beam Radiotherapy techniques
Management of cacrinoma cervix: Techniques of radiotherapy (2D conventional, 3D Conformal radiotherapy (3DCRT) and IMRT with a review of various contouring guidelines.
IMRT and 3D CRT in cervical Cancers
IMRT and 3 DCRT in cervical Cancers - Principles, Uses, Methods and Planning. A short summary of results of contemporary series are also provided.
Accelerated partial breast irradiation
Accelerated partial breast irradiation (APBI) delivers radiation to only the portion of the breast at highest risk of recurrence rather than the whole breast. This allows radiation to be delivered in a significantly shortened period. Several techniques for APBI exist including brachytherapy using catheters implanted in the breast, balloon brachytherapy, and external beam radiotherapy. Ongoing clinical trials are evaluating outcomes and toxicities of APBI compared to whole breast irradiation in appropriately selected patients with early-stage breast cancer.
Cervical carcinoma
This document provides information on carcinoma of the cervix, including epidemiology, risk factors, diagnosis, pathology, stages of pre-invasive and invasive lesions. It discusses that carcinoma of the cervix is the most common genital cancer in India, accounting for 15% of cancers in women. Risk factors include early age of first sexual intercourse, multiple partners, early first pregnancy, and infections like HIV and HPV. Screening is mainly done via Pap smear but can be improved with HPV testing, visual inspection with acetic acid, and colposcopy if needed. Pre-invasive lesions are classified as CIN I-III. Invasive cancers are mostly squamous cell carcinoma or adenocarcinoma, and treatment depends on
Radiotherapy lymphoma
Radiotherapy is used as primary treatment for early-stage Hodgkin lymphoma or as part of combined modality treatment with chemotherapy. Historically, large mantle fields covering lymph node regions from the skull to the pelvis were used. More modern approaches use smaller involved field radiotherapy targeting only initially involved lymph node regions after chemotherapy based on imaging. Proper delineation of clinical target volumes requires pre-chemotherapy imaging ideally with PET/CT to define original disease extent.
Breast Cancer Radiotherapy
This document summarizes recent developments in breast cancer radiotherapy. It discusses a recent meta-analysis of breast cancer radiotherapy trials involving 42,000 women which found that radiotherapy reduces 15-year breast cancer mortality by 5-10% and overall mortality by 4.4%, compared to no radiotherapy. Newer targeted radiotherapy techniques like partial breast irradiation and intensity-modulated radiation therapy (IMRT) are explored which may improve outcomes by more conformally targeting radiation doses to the breast tissue and reducing doses to nearby organs. However, long-term data on these newer techniques is still pending and questions remain around patient selection and appropriate treatment margins.
Sarcoma brachytherapy updates
Brachytherapy improves local control rates for soft tissue sarcomas of the extremities when used as adjuvant therapy after surgery. Interstitial brachytherapy results in 5-year local control rates of 82% for high-grade lesions compared to 69% without brachytherapy. Deeper and larger tumors have worse outcomes, while doses over 60 Gy provide better local control, disease-free survival, and overall survival. Recent data shows intensity-modulated radiation therapy may provide similar local control to brachytherapy with fewer complications. Brachytherapy remains useful for sites where target volumes are extensive or critical structures preclude external beam radiation.
Petct In Gynecologic Cancer
1. PET/CT is useful for diagnosing and staging gynecologic cancers like cervical and ovarian cancer by identifying lymph node and distant metastases that may be missed by conventional methods.
2. A study of 120 cervical cancer patients found that PET/CT identified more extensive disease in 20% of patients compared to conventional staging, including para-aortic lymph node metastases.
3. PET/CT improves radiotherapy planning for cervical cancer by precisely locating tumor tissue and organs at risk, allowing dose escalation with techniques like IMRT while reducing dose to surrounding healthy tissues.
Radiation therapy in gynecologic cancer 17-03-15
Radiation therapy in gynecologic cancer 17-03-15Mahatma Gandhi Medical college & Research Institute - Pondicherry
Radiation therapy plays a major role in treating gynecologic cancers. Developments like X-rays, radium, and artificial radionuclides allowed radiation therapy to be used for various malignancies. Modern linear accelerators and brachytherapy machines deliver external beam radiation therapy or implant radioactive sources. Treatment aims to maximize tumor cell death while minimizing damage to healthy cells. Intensity modulated radiation therapy further improves this goal by conforming the dose to the tumor shape. Developments like image-guided radiation therapy help account for organ motion and changes during treatment. Radiation therapy combined with chemotherapy and surgery provides improved outcomes for cervical and endometrial cancers compared to radiation alone.Adjuvant radiation based on genomic risk factors emerging scenarios
Presentation on tailoring adjuvant radiotherapy for breast cancers based on Genomic risk prediction methods - a review. Presented in MVR CANCON 2018
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
1) Surface guided radiotherapy uses optical cameras to track the external surface of a patient in real-time during treatment and provides sub-millimeter accuracy for patient positioning and motion management.
2) The technique has been used at MSKCC for several clinical applications including frameless SRS for brain tumors, head and neck cancers, and deep inspiratory breath hold treatments for breast cancers.
3) Preliminary results found surface guided radiotherapy improved patient comfort for frameless SRS over framed SRS and doubled the treatment throughput. Motion tracking also ensured frameless SRS accuracy to within 1mm.
Oligometastases
Overview about evolution of the term Oligometastases,the paradigm and various states of oligometastases,treat options ,clinical trials and relevance in current clinical practice
CA ENDOMETRIUM-KIRAN.pptx
1) Endometrial cancer is the most common gynecologic cancer in developed countries, with a lifetime risk of 1 in 35 women. It occurs most often in postmenopausal women.
2) Diagnosis involves endometrial biopsy or dilation and curettage to obtain tissue samples. Staging involves total abdominal hysterectomy and bilateral salpingo-oophorectomy.
3) For low-risk early-stage disease, no additional treatment is typically needed. For high-risk early-stage disease, adjuvant pelvic radiation with or without chemotherapy is recommended based on trials such as PORTEC-3.
Volumetric Modulated Arc Therapy
This document discusses the clinical implementation of volumetric modulated arc therapy (VMAT) at UT M.D. Anderson Cancer Center. It provides an overview of VMAT, the advantages it offers over other radiation therapy techniques, and the steps taken to configure the accelerator, treatment planning system, and quality assurance processes for VMAT delivery. Key aspects covered include accelerator prerequisites, TPS commissioning, patient-specific quality assurance using films and ion chambers, monthly constancy checks, and tips for rapid arc treatment planning for prostate cases.
Radiotherapy for Prostate Cancer
This document discusses radiation therapy options for prostate cancer. It notes that treatment depends on risk level: low risk may receive external beam radiation or seeds alone, intermediate risk should receive some external beam, and high risk should receive hormone therapy plus radiation. Newer techniques like IMRT and IGRT reduce side effects by more precisely targeting the prostate. Side effects of radiation include short term issues like urinary frequency and diarrhea as well as long term risks like radiation cystitis and impotence in some cases.
image guided brachytherapy carcinoma cervix
IMAGE GUIDED BARCHYTHERAPY
AMERICAN BRACHYTHERAPY GUIDELINES
GEC-ESTRO GUIDELINES
LIMITATIONS OF (2 D)RADIOGRAPHIC IMAGING
VOLUMETRIC IMAGING
ADVANCES
Hemi body irradiation
This document discusses hemi body irradiation (HBI) technique used to treat metastatic cancer. HBI involves irradiating only the upper or lower half of the body using parallel opposed radiation fields. It has advantages over total body irradiation like smaller field size and less side effects. HBI is used to palliate widely metastatic disease and as adjuvant therapy for certain cancers. Potential complications include nausea, diarrhea, pneumonitis and hematological effects. The document also provides an overview of cancer registries in India, which systematically collect cancer data to help understand cancer patterns and guide control programs. Population-based and hospital-based registries use active and passive methods to collect data on cancer incidence, stages and survival.
carcinoma breast RADIOTHERAPY TECHNIQUES
This document discusses various radiation therapy techniques for breast carcinoma, including indications for radiation, simulation techniques, post-mastectomy radiation techniques, nodal irradiation techniques, contouring guidelines, boost techniques after breast conservation surgery, intensity modulated radiation therapy (IMRT), and accelerated partial breast irradiation (APBI). It covers topics such as treatment positioning and fields, target volume delineation, dose schedules, and techniques for nodal irradiation and tumor bed boosting.
What's hot (20)
Adjuvant radiation based on genomic risk factors emerging scenarios
Adjuvant radiation based on genomic risk factors emerging scenarios
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
More from umesh V
Stereotactic radiosurgery and radiotherapy
This document discusses stereotactic radiosurgery and radiotherapy. It begins with an introduction to stereotaxy and how it allows for highly precise radiation targeting. It then covers radiobiology concepts relevant to stereotactic radiation and lists some common indications for its use, including brain metastases and early stage prostate cancer. The document provides details on patient immobilization, planning techniques, and treatment procedures for conditions like pituitary adenomas, trigeminal neuralgia, and arteriovenous malformations.
Stereotactic radiosurgery in arterio venous malformations
Stereotactic radiosurgery (SRS) is an effective treatment for arteriovenous malformations (AVMs). SRS precisely delivers high doses of radiation to the AVM nidus, resulting in progressive occlusion of vessels within 1-3 years. Obliteration rates after SRS range from 35-92%, with higher rates for smaller AVMs receiving higher radiation doses. Careful targeting of the AVM nidus using fusion of imaging modalities is important for treatment planning. Long-term follow up with MRI is needed to monitor for obliteration and potential radiation-related effects.
Contouring guidelines of carcinoma cervix
This document provides contouring guidelines for radiation treatment planning of carcinoma of the cervix. It outlines the key anatomical targets and organs at risk that must be delineated, including the gross tumor volume, clinical target volume for the primary tumor and lymph nodes, planning target volume, and organs like the bladder and bone marrow. It also discusses important aspects like bladder filling protocol, dose prescription for the tumor and nodes, use of intensity-modulated radiation therapy to spare organs at risk, and set up verification during treatment.
Management of carcinoma vulva
This document discusses the management of carcinoma of the vulva. It covers topics such as anatomy, epidemiology, etiology, pathology, presentation, investigations, prognosis, treatment for early and late stage disease including surgery, lymph node dissection, radiotherapy, brachytherapy, chemotherapy, follow up, and melanoma and Paget's disease of the vulva. Key points discussed include that treatment is recommended for all women with vulvar HSIL, wide local excision should be performed if cancer is suspected, and HSIL can also be treated with other local methods. Lymph node involvement is an important prognostic factor, and sentinel lymph node biopsy is used to detect lymph node metastases. Radiotherapy may be used as pre-
Stereotactic body radiation therapy
Several institutions have studied stereotactic body radiation therapy (SBRT) for primary lung cancer. Indiana University studies showed a maximum tolerated dose of 66 Gy for T2 lesions delivered over 3 fractions, with 1-year local control rates of 98%. Other studies from Aarhus University, Kyoto University, Air Force General Hospital in Beijing, and University of Marburg demonstrated 1-2 year local control rates ranging from 85-95% using SBRT dose fractions between 30-60 Gy delivered over 1 to 10 fractions.
Carbon ion therapy
Heavy ion therapy uses ions heavier than helium for radiation therapy. The National Institute of Radiological Sciences in Japan and the GSI in Germany were early adopters of heavy ion therapy using carbon ions. Additional facilities in Japan, China, and Germany have since come online, demonstrating the increasing use of heavy ion therapy globally. Key advantages of heavy ion therapy over photon therapy include improved targeting of tumors and reduced radiation exposure of surrounding healthy tissue.
Intra operative radiotherapy (iort)
Stereotactic body radiation therapy (SBRT) provides a single targeted dose of radiation during breast cancer surgery, saving time for patients and reducing side effects compared to external beam radiation over several weeks. A team approach using SBRT is an effective alternative treatment for early stage breast cancer.
Stereotactic Radiosurgery/ Radiotherapy
This document discusses stereotactic radiotherapy and radiosurgery. It begins by explaining that stereotactic radiotherapy precisely delivers radiation doses to defined tumor volumes, sparing surrounding normal tissues, using an external coordinate system attached to the patient. Stereotactic radiotherapy involves fractionated doses while radiosurgery delivers a high single dose. Imaging is used to delineate the target and organs at risk. Treatment planning software is then used to plan radiation techniques delivering a steep dose gradient. Quality assurance protocols ensure precise dose delivery. Indications, advantages, and limitations of stereotactic radiotherapy and radiosurgery are provided. The document concludes by discussing advances and other modalities like proton radiosurgery.
More from umesh V (8)
Stereotactic radiosurgery in arterio venous malformations
Stereotactic radiosurgery in arterio venous malformations
Recently uploaded
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
10 Benefits an EPCR Software should Bring to EMS Organizations
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Recently uploaded (20)
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Role neoadjuvant chemotherapy in ca cervix
- 7. Followed by Radiotherapy with Radiotherapy Alone in Patients with Locally Advanced Cervical Cancer SURVIVAL RATES Study Year Pati ents Stages Drugs CT + RT (%) RT Alone (%) P End Point Kumar et al. 1994 184 IIB-IVA BIP 38 43 0.5 OS @32m Tattersall et al. 1992 71 IIB-IVA PVB 44 40 NS OS @48m Chauvergne et al. 1990 107 IIIB MtxCVP 47 50 NS OS @48m Tattersall et al 1995 260 IIB-IVA EpP 50 69 0.02 OS @36m Sundr et al 1996 94 IIIB-IVA PF 34 37 0.9 OS @48m Leborgne et al 1997 96 IB2-IVA BOP 38 45 0.4 DFS@ 60m Souhami et al. 1991 107 IIIB BOMP 23 39 0.02 OS @ 60m